Clinical Trial

Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this protocol is to investigate, using functional magnetic resonance imaging (fMRI), the effect of treatment with lorcaserin on centers of the brain that control appetite and food intake, as well as lorcaserin's downstream metabolic effects.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2015-03-26; most recent amendment 2026-04-27.
Status change: Recruiting → Active, Not Recruiting 2015-09-15
Trial Details
NCT Number NCT02400359
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Obesity, Weight Loss
Enrollment 40 participants
Start Date 2014-10
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-01